Filter By Unselect All

Sub Category Unselect See All

Country Unselect See All

Companies Unselect See All

AMRI (1)

Grace (1)



Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

CMO Micronization

API & Drug Product Development >> API Development >> Micronization

By using microfluidization technology process, Skyepharma provides solution to increase bioavailabity of poorly soluble APIs. It is also an interesting technology for micro and nano emulsion manufacturing.

Research & Development

API & Drug Product Development >> API Development >> Scale-Up Capabilities

The mission of PMC ISOCHEM's R&D consists of chemical, process & analytical R&D, up-scaling & production improvement. Thanks to a broad technology platform & lifecycle management experience, PMC ISOCHEM's R&D team takes your product to the next level.

Synthetic Research & Process Development

API & Drug Product Development >> API Development >> Process Development & Optimization

Minakem High Potent's R&D department main functions include synthetic research and process development; analytical research and development; continuous improvement.

Developing New Synthetic Methods

API & Drug Product Development >> API Development >> Route Evaluation & Development

Biondustria L.I.M's R&D Laboratories are in charge of developing new synthetic methods.

Development of Chemical Procedures

API & Drug Product Development >> API Development >> Process Development & Optimization

Our priority lies in the development of chemical procedures which are subsequently used in the making of products sold not only on Czech markets, but more importantly abroad.

Synthesizing Impurities

API & Drug Product Development >> API Development >> Impurity / Reference Standard

State-of-the-art R&D center is located in our Ankleshwar facility. Highly qualified professionals with the scientific bent of mind are working in product development, analytical development and intellectual property rights.

Support All Your Hazard Evaluation Needs

API & Drug Product Development >> API Development >> Process Safety Assessment

During early process development, AMRI’s experts conduct a safety evaluation to identify potential issues during scale-up. At that stage and based on our evaluation, we redesign the processes to address all potentially hazardous issues.

Offers More Than 6500 Biologically Active Peptides

API & Drug Product Development >> API Development >> Protein / Peptide

Bachem is specialized in the development and the manufacturing of biologically active peptides and complex organic molecules as active pharmaceutical ingredients (APIs) and as innovative biochemicals for research purposes.

API Development Process Optimization

API & Drug Product Development >> API Development >> Process Development & Optimization

LEBSA offers an end-to-end partnership for custom API development, scale-up and manufacturing with a flexible multipurpose EU GMP Pilot Plant, from grams to tones, with a client centric approach.

Microbial Fermentation (Yeast & Bacteria)

API & Drug Product Development >> API Development >> Biocatalysis

SAIS is a microbial fermentation CDMO service provider. It produces small molecules via fermentation for pharma and food industry. SAIS is a microbial fermentation CDMO which offers contract API development services including yeast and bacterial fermentation CDMO capabilities.

What is API Development?For ContractAPI Development services, Active pharmaceutical ingredient (API), is theterm used to refer to the biologic is API Development?

For ContractAPI Development services, Active pharmaceutical ingredient (API), is theterm used to refer to the biologically active component of a drug product (e.g.tablet, capsule). Drug products are usually composed of several components.


The aforementioned API is the primaryingredient. Other ingredients are commonly known as "excipients" andthese substances are always required to be biologically safe, often making up avariable fraction of the drug product.


The procedure for optimizing andcompositing this mixture of components used in the drug is known as"formulation". For example, if the API is a solid and the drug isrequired to have a liquid dosage form, such as a cough syrup, then theexcipients would be the liquids that are used to formulate the syrup.


The Photochemistry services designcriteria for any small molecule API is usually a combination of several factorsthat goes beyond the intended therapeutic effect, and usually heavilyencompasses both pharmacokinetic and pharmacodynamic considerations, so forthis reason, API molecules have many chemical functional groups.


The API form API Process Development thatis used in a formulation is often the most Phosgenation services thermodynamicallystable crystalline form. As such, the phenomenon of hydrogen bonding incombination with there being many functional groups on the API usually resultsin the available crystalline form being a hydrate.


Themission of an API Development CDMOis to provide complete services in chemical, process & analytical R&D,up-scaling & production improvement. With the help of a broad technologyplatform & lifecycle management experience, a notable API development andR&D team takes product to the next level with Top Cold Chemistry services partner.


Similarly,a API development GMP certifiedfacility with High Potent R&D department main functions include syntheticresearch and process development; analytical research and development;continuous improvement.


Choosean API Development and Manufacture CDMOwhose priority lies in the development of chemical procedures which aresubsequently used in the making of products sold not only on Czech markets, butmore importantly abroad.

Findthe information on APIProcess Safety Assessment services to get in touch with an API Development and Manufacture oriented State-of-the-art R&Dcenter with highly qualified professionals working in product development,analytical development and intellectual property rights.


What processes for GMP for APIspractically applied?


Duringearly process development, cGMP APIdevelopment expert will be able to conduct a safety evaluation to identifypotential issues during scale-up Protein API development Services. At that stage and based on itsfurther evaluation, the API redesign with BiocatalysisCDMOs facilitates processes to address all potentially hazardous issues.


Alongwith Separation & Purification, Thereare Cold Chemistry servicesspecialized in the development and the manufacturing of biologically activepeptides and complex organic molecules as API Protein development services and as innovative biochemical forresearch purposes including Peptidedevelopment services.


Itis important to know the internalities of GMPfor APIs practically applied in APIdeveloping companies which specialize in manufacturing, supplying, andcustom synthesis latest chemicals. Peptidecustom synthesis services cover all kinds of pharmaceuticals and treatments.


Fine Chemical / Intermediate offers an end-to-endpartnership for custom API development, scale-up and manufacturing Protein CDMO services with aflexible multipurpose EU GMP Pilot Plant, custom protein development services fromgrams to tonnes, with a client centric approach up to Spray Drying services.


Thefour most common out-of-scope project costs depends on API Development CDMO with emphasis on Development Cost and Raw Materials and Custom Synthesis CDMO.


There’s a cGMP API drug product development service for Active Pharmaceutical Ingredients and the same is true for budgeting. Numerous factors come into play in almost every project, and at every stage of the project. Always, there are unknowns. That’s why quoting in intermediatesdevelopment services CDMO business is an educated guess at best.  At worst, it’s a disingenuous ploy to make the project price seem more competitive than it will ultimately turn out to be.


In previous Reference Standards CDMOs, we’ve discussed at greater length some of reasons project costs could escalate.


Customprotein CDMOs will focus on the four most commonreasons for out-of-scope charges that may require additional funding. High Pressure Reactions CDMOs arefrequent source of cost overruns is add-ons by Crystallization Process services. As the chemistry for an API Spray Drying services develops, and if it looks promising, it’s not unusual for a Peptide APIs service providers sponsorto decide to invest more in the asset for several reasons.


One is that the Distillation / Liquid APIs R&D yields additional results with Halogenation services to unlock more value than initially expected. Another Crystallization Process services is to have a better shot atlicensing to a big pharma. A potential licenser may not want to spend another1.5 or two years developing an API. A cGMPAPI drug product development CDMO expects the High Potency APIs development service to enhance the value of theasset ahead of any licensing conversations.


HydrogenationCDMOs have seen plenty of situations where APIProcess Safety Assessment services andHigh Pressure Reactions CDMOs have invested the time and effort in a drugcandidate and were rewarded.  If High Pressure Reactions CDMOs have donea good job of de-risking the APIHalogenation services, which Micronizationservices usually recommend, for PeptideAPIs development in big pharmawill know they can have a secure and reliable supply chain, a key decisionpoint in their Scale-Up Capabilities.In those cases, the conversation moves more quickly from which Hydrogenation CDMOs is worth to alicensing discussion. Indeed, investing in a promising asset pays Custom protein CDMOs with increasedquality assurance.


Conversely, Ozonolysis services are required pharmaceutical companies walk awayfrom licensing less developed assets.  IfLow temperature service providers deem the risk of having to spendsignificantly more time and effort to develop the API for clinical trials, it’s usually interested in Route Evaluation & Development.


HazardousRaw materials

Thequality of the raw materials used in any APIdevelopment project are important building blocks.  We use numerous reliable sources for rawmaterials. But even with the most diligent sourcing Route scouting development and the close alliances, Peptide APIs CDMOs maintain withtrusted Route scouting services suppliers,there are many RadiolabelledCompoundsthat may be handled during APIdevelopment.

Asin other RouteEvaluation & Development requirements on the topic of raw materials, Reference Standards CDMOs should not unacceptable foreignmatter in the raw materials. Or when we test batches before accepting andstocking them, Cryogenic Conditions CDMOs can determinethe level of impurities exceeds the amounts specified in our GMP protocols.Those are both non-starters. Routescouting service providers would have to find higher quality or differentraw materials that may be costlier before the project can move forward.


Otherraw material issues also can add cost to an API project. The evolving chemistrymay dictate that we use more of a raw material to reach a desired yield, forexample.


Howmuch to set aside for API route scoutingCDMOs costs?

The rule of thumb for doing a home kitchen renovation project is to expect to spend 30% more than you budgeted. Likewise, there’s a rule of thumb for out-of-scope items in API development projects. Prepare to spend an additional 15-20%.


Theamount varies from project to project of course and may not be needed, but setaside the funds to be prepared if additional funding is needed. Developing newchemistry for every API project is a complex and time-consuming endeavor.Although some Peptide CDMO servicesprojects do go smoothly, most require either more analytical work or issues areencountered somewhere along the line that must be resolved.


If a big pharmaceutical company does become interested in that promising asset, you don’t want them to walk out the door because the analytical work was incomplete or the project wasn’t far enough along in its development.


Whereare the extra costs incurred in APIRoute evaluation services?

There are several different stages at which additional costs could materialize—in R&D, in analytical work, and in manufacturing.


At CDMO Service Providers or CDMOswith API development capabilities, API CDMOs tend to be conservative onthe time it takes to do detailed analytical work and inevitably Organometallic Chemistry Services are asked to pare that backsome. But most often API development service providersup adding CustomAPIs back in, as it’s what the pharma companies and the regulators will be looking closely at API development capabilities.


Whenthe focus on API Process optimization from thebeginning, API development coststend to be lower overall.  The work on Custom APIs gets done more efficientlyand the work is completed with a high level of quality

APIseparation CDMO service providers know no one wants to spend more money than necessaryand Micronization CDMOs are veryproactive in looking for money-saving solutions. Scale Up CDMOs For example, in one API purification service providers polymer projects thesubstance was being made in less than ideal conditions. The API development services sponsor wanted a 2nd, GMP compliant API purification CDMO services source. However, thecost-benefit analysis Low temperature service providersdid showed the costs would be too high, and Impurity CDMOsare recommended against a secondary source along with Protein purificationCDMOs. It would have required a great deal more time and exceeded the asset’s value for Protein purification CDMOs


APIRoute development services at the Highest QualityStandards

Therule of thumb is that most APIdevelopment projects will cost 15-20% more than budgeted due toout-of-scope project costs and addendums. Until a Scale Up developmentservices project is well under way, it’s hard to know with new chemistry of Scale Up development services whetherprocesses will change, requiring additional analytical work, or if the currentraw materials will suffice. Putting the additional funding aside de-risksprojects for API scale up development, assuring theywill be completed to the specifications required by big pharma and regulators.


API Development and Manufacture – Early Phase

Protein Separation CDMO services and Peptide CDMOs ensure that they have significant experience in thefirst time Scale-UpCapabilitiesof APIs. Starting with the medicinal chemistry route, our knowledgeablechemists can quickly identify the most pressing parts of the chemistry todevelop.


API Development and Manufacture – Late Phase


Supporting Late Phase API Development andCommercial Launch

Wehave an established reputation for developing processes for late clinicalstage. Top High Pressure Reactions CDMOs extensive experience lies intaking custom peptide service providers processesfrom inception through to process validation, both in small molecule chemistryand peptides, custom peptide services.As an API moves from early clinical phase towards late clinical phase, theemphasis of the project changes. Whereas in early clinical supply, a leanfit-for-purpose approach is appropriate, other factors start to dominate whenmoving towards late phase, particularly process efficiency and knowledge.


OrganometallicCDMOs and Fine Chemical / Intermediate API Development and Manufacture strategicallyintegrate Custom API development processes with the principles fromregulatory guidelines (FDA, ICH, USP), such as risk management and quality bydesign, as a basis for development and manufacturing strategies.

The high quality API development GMP certified CDMO has the strength in API development and manufacture isproven by being the Custom APIdevelopment partner of choice for many pharma and biotech companies seekingintegrated drug development solutions from molecule to market.


The technical expertise and extensivefacilities of Micronization services enableoffer integrated API contractmanufacturing solutions through all stages of the drug developmentlifecycle.  Custom API CDMOs are fully supported by dedicated analytical andregulatory teams along with MicrowaveChemistry Services.


In addition, API Development and Manufacture with Ozonolysis services offer numerous support capabilities, including:rapid implementation of chromatography for purification, containment equipmentfor potent compounds and Micronizationservices to control particle size.  Adynamic team of Fine chemicals CDMOservices successfully address many complex project challenges, andimplementing our on-site biocatalysis technology expertise is one example ofour responsive solutions.


Project management is critical for the effective execution and delivery of our customers’ complex projects.  HPAPIsdevelopment services have project managers are Fine chemicals development experienced scientists, HPAPIs CDMOs working with clients toanticipate and respond to project priorities.


APIDevelopment and Manufacture with Ozonolysis services has an excellentregulatory history with regular inspections by all appropriate regulatory bodies(FDA, MHRA) and the clients of Top API development GMP certified companies